「Cox2」の共起表現一覧(1語右で並び替え)
該当件数 : 29件
Simmons discovered the | COX-2 and COX-3 enzymes. |
matory polyphenols would be down-regulation of | COX-2 and iNOS through suppression of NF-κB activati |
Two cyclooxygenase isozymes, COX-1 and | COX-2, are known to convert arachidonic acid into pr |
upport for the idea that other targets besides | COX-2 are important for celecoxib's anticancer effec |
In terms of their molecular biology, COX-1 and | COX-2 are of similar molecular weight, approximately |
inhibiting cyclooxygenase-1 and -2 (COX-1 and | COX-2) enzymes reversibly, which decreases productio |
of enzymes also contain heme B. The COX-1 and | COX-2 enzymes (cyclooxygenase) of recent fame, also |
but it is thought to act on enzymes COX-1 and | COX-2, inhibiting prostaglandin synthesis. |
Selective | COX-2 inhibitor NSAIDs |
Anitrazifen is a drug displaying | COX-2 inhibitor activity. |
NS-398 is a | COX-2 inhibitor used in the study of the function of |
Firocoxib was the first | COX-2 inhibitor approved by the U.S. Food and Drug A |
Even before the first selective | COX-2 inhibitor was marketed, specialists had doubts |
a non-steroidal anti-inflammatory drug of the | COX-2 inhibitor (coxib) class, currently approved fo |
The COX-1 and | COX-2 inhibitor medications, used to treat inflammat |
mach than other NSAIDs except for drugs of the | COX-2 inhibitor class. |
, in 1934; Dramamine, for motion sickness; the | COX-2 inhibitor Celebrex; Ambien for insomnia; and N |
Celecoxib ( | COX-2 inhibitor) |
essionals to exercise caution when prescribing | COX-2 inhibitors to patients with risk factors for h |
Some of these analogs retained | COX-2 inhibitory activity, whereas many others didn' |
COX-2, on the other hand, is undetectable in most no | |
They are produced by the | COX-2 pathway especially in the presence of aspirin. |
Series-1 prostanoids, via the COX-1 and | COX-2 pathways. |
boxanes with 1 double-bond), via the COX-1 and | COX-2 pathways. |
Relatively new drugs, known as | COX-2 selective inhibitors or coxibs, are used as sp |
d stroke in users of NSAID drugs, particularly | COX-2 selective NSAIDs such as celecoxib, since the |
r or not the respective compound could inhibit | COX-2, showing that inhibition of COX-2 was not requ |
stitutive COX-1 (this enzyme) and an inducible | COX-2, which differ in their regulation of expressio |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |